• Sygnature Discovery Establishes U.S. Ops contractpharma
    November 28, 2018
    Sygnature Discovery, a drug discovery and preclinical services company, is expanding its operations with the opening of its first U.S. office in Harvard Square, Cambridge, MA.
  • Piramal Unveils New cGMP Kilo Lab Suite for APIs contractpharma
    November 27, 2018
    Piramal Pharma Solutions (PPS) has completed its new cGMP kilo lab suite at its active pharmaceutical ingredient (API) site in Ennore, Chennai, India. The suite will formally open on...
  • Evotec AG, Immuneering in Discovery Alliance contractpharma
    November 27, 2018
    Evotec AG has entered into a research collaboration with Immuneering Corp., a data-driven drug discovery provider, to discover novel small molecules for rare hereditary metabolic diseases. Financial details were not disclosed.
  • GBG & Yale Partner for Drug Discovery contractpharma
    November 01, 2018
    GBG & Yale Partner for Drug Discovery
  • Ground-breaking approach accelerates drug discovery process biospectrumasia
    October 23, 2018
    International study develops innovative method to discover new anti-epileptic drug in record time, with potential to do the same for other diseases.
  • Eisai Launches Dementia Discovery Center contractpharma
    June 19, 2018
    Eisai Inc. announced it will launch the Eisai Center for Genetics Guided Dementia Discovery, which will harness the power of human genetics to develop next-generation medicines for Alzheimer's disease (AD) and other dementias. 
  • Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing b3cnewswire.
    June 04, 2018
    Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing
  • New organ discovery has implications for cancer treatment pharmafile
    March 28, 2018
    The discovery of an entirely new organ, the 80th to be discovered in the human body, could have serious implications for our collective understanding of cancer and a number of other diseases.
PharmaSources Customer Service